Literature DB >> 33000663

Telehealth tinnitus therapy during the COVID-19 outbreak in the UK: uptake and related factors.

Hashir Aazh1, De Wet Swanepoel2,3, Brian C J Moore4.   

Abstract

OBJECTIVE: The Audiology Department at the Royal Surrey County Hospital usually offers face-to-face audiologist-delivered cognitive behavioural therapy (CBT) for tinnitus rehabilitation. During COVID-19 lockdown, patients were offered telehealth CBT via video using a web-based platform. This study evaluated the proportion of patients who took up the offer of telehealth sessions and factors related to this.
DESIGN: Retrospective service evaluation. STUDY SAMPLE: 113 consecutive patients whose care was interrupted by the lockdown.
RESULTS: 80% of patients accepted telehealth. The main reasons for declining were not having access to a suitable device and the belief that telehealth appointments would not be useful. Compared to having no hearing loss in the better ear, having a mild or moderate hearing loss increased the chance of declining telehealth by factors of 3.5 (p = 0.04) and 14.9 (p = 0.038), respectively. High tinnitus annoyance as measured via the visual analogue scale increased the chance of declining telehealth appointments by a factor of 1.4 (p = 0.019).
CONCLUSIONS: Although CBT via telehealth was acceptable to most patients, alternatives may be necessary for the 20% who declined. These tended to have worse hearing in their better ear and more annoying tinnitus.

Entities:  

Keywords:  Tinnitus; audiology; covid-19; telehealth; video

Year:  2020        PMID: 33000663     DOI: 10.1080/14992027.2020.1822553

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  2 in total

Review 1.  Evaluation and Management of Misophonia Using a Hybrid Telecare Approach: A Case Report.

Authors:  Lori Zitelli
Journal:  Semin Hear       Date:  2021-08-02

Review 2.  Tinnitus Management: The Utilization of a Hybrid Telehealth and In-Person Delivery Model.

Authors:  Tricia Scaglione; Brianna Kuzbyt
Journal:  Semin Hear       Date:  2021-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.